Andreas Hillarp
21 – 30 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Comparison of automated von Willebrand factor activity assays.
2015) In Thrombosis Research(
- Contribution to journal › Article
-
Mark
One-stage vs. chromogenic assays in haemophilia A
(
- Contribution to journal › Scientific review
-
Mark
More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
(
- Contribution to journal › Article
- 2014
-
Mark
Laboratory aspects of von Willebrand disease : test repertoire and options for activity assays and genetic analysis
(
- Contribution to journal › Scientific review
-
Mark
Clinically relevant non-neutralizing anti-FVIII antibodies in a hemophiliac
(
- Contribution to journal › Letter
-
Mark
Assay discrepancy in mild haemophilia A
(
- Contribution to journal › Scientific review
-
Mark
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.
(
- Contribution to journal › Article
- 2013
-
Mark
Long-term anti-FVIII antibody response in Bethesda-negative haemophilia A patients receiving continuous replacement therapy.
(
- Contribution to journal › Article
-
Mark
Measuring Oral Direct Inhibitors (ODIs) of thrombin and factor Xa : A recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis
(
- Contribution to journal › Article
- 2012
-
Mark
Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency
(
- Contribution to journal › Article